key: cord-0327045-b99a6xdr authors: Cao, Yue; Lin, Yingxin; Patrick, Ellis; Yang, Pengyi; Yang, Jean Yee Hwa title: scFeatures: Multi-view representations of single-cell and spatial data for disease outcome prediction date: 2022-01-22 journal: bioRxiv DOI: 10.1101/2022.01.20.476845 sha: 14e0f325e8d41e836ed98c13959c2e3171161151 doc_id: 327045 cord_uid: b99a6xdr Recent advances in single-cell technologies enable scientists to measure molecular data at high-resolutions and hold the promise to substantially improve clinical outcomes through personalised medicine. However, due to a lack of tools specifically designed to represent each sample (e.g. patient) from the collection of cells sequenced, disease outcome prediction on the sample level remains a challenging task. Here, we present scFeatures, a tool that creates interpretable molecular representation of single-cell and spatial data using 17 types of features motivated by current literature. The feature types span across six distinct categories including cell type proportions, cell type specific gene expressions, cell type specific pathway scores, cell type specific cell–cell interaction scores, overall aggregated gene expressions and spatial metrics. By generating molecular representation using scFeatures for single-cell RNA-seq, spatial proteomic and spatial transcriptomic data, we demonstrate that different types of features are important for predicting different disease outcomes in different datasets and the downstream analysis of features uncover novel biological discoveries. Recent advances in single-cell technologies enable scientists to measure molecular data at high-resolutions and hold the promise to substantially improve clinical outcomes through personalised medicine. However, due to a lack of tools specifically designed to represent each sample (e.g. patient) from the collection of cells sequenced, disease outcome prediction on the sample level remains a challenging task. Here, we present scFeatures, a tool that creates interpretable molecular representation of single-cell and spatial data using 17 types of features motivated by current literature. The feature types span across six distinct categories including cell type proportions, cell type specific gene expressions, cell type specific pathway scores, cell type specific cell-cell interaction scores, overall aggregated gene expressions and spatial metrics. By generating molecular representation using scFeatures for single-cell RNA-seq, spatial proteomic and spatial transcriptomic data, we demonstrate that different types of features are important for predicting different disease outcomes in different datasets and the downstream analysis of features uncover novel biological discoveries. Recent single-cell or near single-cell resolution omics technologies such as spatial transcriptomics enable the discovery of cell-and cell type-specific knowledge and have transformed our understanding of biological systems, including diseases 1 . Key to the exploration of such data is the ability to untangle and extract useful information from their high feature dimensions 2 and uncover hidden insights. A plethora of computational methods has been developed on this front, with the main focus on individual cell analysis 3 , such as cell type identity 4 5 and pseudotime ordering within a lineage 6 . While these tools enable characterisation of individual cells, there is a lack of tools that allow for the representation of individual samples based on their cellular characteristics and the investigation of how these cellular properties are driving disease outcomes. With the recent surge of multi-condition and multi-sample single-cell studies on large sample cohort 7 , the next frontier of research is on representing and characterising cellular properties at the sample (e.g. individual patient) level for linking such information with the disease outcome. Creating a representation of each sample from the collection of sequenced cells is a crucial step for subsequent analysis as successful modelling and interpretation of disease outcome requires biologically relevant learning features from the data. While using the original expression matrix as the input to various models could inform the change in transcriptomics level across disease conditions, the ability to represent the data with other layers of information is critical for uncovering additional insights given the complex and nonlinear relationships among the feature dimensions (e.g. interaction of genes, gene networks and pathways). The single-cell field has a wealth of tools for data exploration 8 which enables exploration of biology underlying the individuals. Most current tools are not specifically designed to derive a set of features that can be used to represent an individual. Yet, with careful adaptation, a number of approaches can be used to construct novel molecular representations of individual samples. Cell-cell interactions tools 9 , for example, calculate cell type-specific signalling scores between pairs of ligand and receptor molecules. The interaction scores can be used to represent the intercellular communications of cells and cell types in a sample. Another example is gene set enrichment analysis 10 which infers the pathway enrichment score of individual cells. By summarising the scores across cell types, a cell type-specific representation of the pathway enrichment of each sample can be constructed. To this end, we develop scFeatures, a tool that generates a large collection of interpretable molecular representations for individual samples in single-cell omics data, which can be readily used by any machine learning algorithms to perform disease outcome prediction and drive biological discovery. Together, scFeatures generates features across six categories representing different molecular views of cellular characteristics. These include i) cell type proportions, ii) cell type specific gene expressions, iii) cell type specific pathway expressions, iv) cell type specific cell-cell interaction (CCI) scores, v) overall aggregated gene expressions and vi) spatial metrics. The different types of features constructed thereby enables a multi-view of our data and enables a more comprehensive representation of the expression data. In a collection of 17 published single-cell RNA-seq, single-cell spatial proteomics and spatial transcriptomics datasets, scFeatures reveal different feature classes are useful for predicting the disease outcomes in different datasets. Furthermore, through examining the selected features in two case studies, scFeatures uncovers cell types important to ulcerative colitis and stratified patients with distinct survival outcomes in triple negative breast cancer patients. Together, these results demonstrate that scFeature enables a data-driven generation (or feature engineering)and facilitate unbiased identification of feature classes most perturbed by the disease conditions. Results scFeatures performs multi-view feature engineering for single-cell and spotbased data We propose scFeatures, a new multi-view feature engineering framework that creates an interpretable representation of cellular level features for each individual sample from a given single-cell or spot-based expression dataset (Fig. 1a) . To capture the wide range of cellular information for sample classification (e.g., patients versus healthy individuals) using single-cell data, we implemented an extensive collection of algorithms to extract over 50,000 interpretable features from a given dataset. These features, spanning a total of 17 types, are motivated by established analytical approaches in a broad range single-cell literature and can be broadly grouped into six distinct categories including i) cell type proportions, ii) cell type specific gene expressions, iii) cell type specific pathway expressions, iv) cell type specific CCI scores, v) overall aggregated gene expressions and vi) spatial metrics (Fig. 1b) . These collections of constructed features can then be used for various downstream analysis such as disease outcome prediction, biomarker selection, survival analysis and enable the identification of interpretable features and feature types associated with disease conditions. The six feature categories represent different "views" of the single-cell information. Specifically, category I captures cell type proportion information in which the proportion of cell types for each sample and the ratio of proportions between two cell types are measured. Category II represents cell type specific gene expression, and examines the expression of sets of genes or proteins in each cell type. We implemented different approaches for representing genes or proteins measurement, including average expression, proportion of expression and correlation of expressions. In category III, which calculates cell type specific pathway scores, by default the 50 hallmark pathways in the Molecular Signatures Database (MSigDB) 11 12 were used to generate various features such as the average expression of each pathway in each cell type. Category IV contains the CCI scores, measuring the probability of ligand-receptor interaction based on the expression values of each sample. Category V is designed to recreate the bulk expression through aggregating the expression across cells or spots depending on the data types. Category VI is designed specifically for spatial data type for capturing spatial information and includes classical metrics for identifying spatial patterns. scFeatures extracts interpretable features from data generated by scRNA-seq, spatial proteomics, and spatial transcriptomics ( Table 1 ). In particular, spatial transcriptomics data, is a spot-based technique in which the expression value of each spot is based on a small population of cells often containing cells from multiple cell types. We developed several novel ways to adapt the 13 feature types to spot-based data whenever possible; this collection of spatial metrics takes into consideration the properties of spot-based technology and reveals cell typespecific features in spot-based data. For example, spot-based data precludes direct application of cell type proportion computation since each spot includes an unknown number of cells while cell type percentage estimation requires individual cell counts for each cell type. To overcome this issue, we estimated the number of cells in each spot using the library size of that location, based on the association between the two values. Supplementary Table 1 provides more documentation on the implementation details on the adaptation of feature types from single cell RNA-sequencing to spot-based technologies. scFeatures generates large collection of diverse features and is scalable to large datasets To demonstrate the characteristics of the feature representation, we applied scFeatures to 17 datasets measured using scRNA-seq, spatial proteomics and spatial transcriptomics data ( Table 2) . For a typical scRNA-seq data, scFeatures generated over 50,000 features (Fig. 2a) . As expected, the number of features generated were mostly associated with the number of cell types in the dataset and not other data characteristics such as number of genes, number of cells and number of patients (Supplementary Figure 1) . To explore the complementarity among the features generated from scFeatures, we examined the correlation between the features across 17 datasets. We observed a mosaic pattern, where feature types from the same feature category tended to have higher correlations with each other but very low correlation with feature types from other categories ( Figure 3) , we found that, overall, the feature types were poorly correlated ( Fig. 2c) with the median correlation between feature types ranges between 0.1 to 0.25 (Fig. 2c ). The relatively low correlations indicate that the features constructed by scFeatures were diverse and potentially complementary for exploring disease outcomes. The top three correlated pairs were observed amongst feature types related to overall aggregated gene expression. This is consistent with our expectation of some degree of co-expression linked with various conditions (e.g., healthy or disease outcome), and it is important to emphasise that these top correlated features remain poorly correlated. We next benchmarked the runtime and memory requirement of the feature types on single-cell scRNA-seq (Supplementary Figure 4a) , spatial proteomics (Supplementary Figure 4b) , as well as on spot-based spatial transcriptomics datasets (Supplementary Figure 4c) for evaluating both the single-cell RNA-sequencing implementation and the spot-based implementation. All datasets contain 1,000 to 100,000 cells. On the largest datasets with 100,000 cells, the majority of feature types took less than a minute to compute when executed on eight cores, demonstrating that scFeatures is highly scalable to large datasets. As expected, there was some trade-off between processing time and memory. As a result of parallel computation over eight cores, some feature types required more than 10GB of RAM in total; however, users can run on a single core to decrease the memory required. The most informative features classes differ between different datasets. We hypothesised that distinct feature classes would be informative for different datasets since each dataset comprises samples with varying characteristics and disease outcomes. Several datasets were used where each feature type was evaluated on their ability to predict disease outcomes and the observations are in alignment with our hypothesis. First, we used a lung disease dataset collection where the cells were split into the epithelial, immune and fibroblast subset and the outcome of interest was to classify the patients into healthy or idiopathic pulmonary fibrosis (IPF). In Fig. 3a , we visualised the performance classification of the feature types on the three subsets and ordered the feature types according to their performance in the epithelial subsets. This reveals that feature types that achieved the highest accuracy in the epithelial subset are related to cell type proportions (i.e., "proportion ratio", "proportion logit" and "proportion raw") ( Fig. 3a) . In contrast, the performance of feature types on the immune and fibroblast subset clearly does not follow the same trend as on the epithelial subset, demonstrating that different feature types are useful to the three datasets Similar observation is also found in the melanoma pre-treatment dataset and melanoma posttreatment dataset where the question of interest is classifying non-responder and responders. Fig. 3b illustrate that proportion features (i.e., "proportion raw" and "proportion logit") more accurately classified patients in the post-treatment dataset than patients in the pre-treatment dataset and pathway features (i.e, "pathway gsva" and "pathway proportion") provides more accurately classified pre-treated patients. We then examined across 17 datasets (Supplementary Figure 5 ) and highlighted the five informative feature types for each dataset (Fig. 3c) for a more comprehensive assessment of the performance of the feature types. Across the 17 datasets tested, "gene mean celltype", which examines expression in cell type specific manner, occurred in 10 datasets as the top five informative feature types. This is perhaps not surprising, as it elucidates the power of single-cell technology and the ability of cell type specific gene expression to uncover changes in response to diseases. Across the spatial datasets, we saw feature types in the spatial feature category appearing as the top five informative feature types, indicating the usefulness of this category for capturing spatial information and the potential of spatial data modality offering complementary information. All together, these findings highlight that different feature types are useful for exploring disease mechanisms in different datasets and even in different subsets of the same dataset, as seen by the pre-and post-treatment melanoma patients and the lung disease dataset subset by cell types, and argue for the need for a diverse compendium of feature types for such analyses. scFeatures provides interpretable insight into disease outcome from scRNA-seq data To illustrate that scFeatures provides interpretable features for disease understanding, we applied scFeatures on the "UC healthy vs non -inflamed (Fib)" dataset 13 . This scRNA-seq dataset compares fibroblast cells of non-inflamed biopsies from ulcerative colitis (UC) patients and biopsies from healthy patients. We focused on the two top performing feature types based on the classification model performance from the previous section of "gene mean celltype" and "cell type proportion raw" (Fig. 3c ) and discovered different sets of cell types were important to the two feature types. For the feature type based on cell type specific gene expression (denoted by "gene mean celltype"), the top four cell types according to feature importance score (see Methods) are all sub-cell types from WNT2B+ and WNT5B+ cells (Fig. 4a ). This indicates that selected features, i.e., genes, from these cell types were considered more important at predicting disease outcomes than genes of other cell types. In contrast, the WNT2B+ and WNT5B+ cell types were ranked as the bottom four cell types in terms of the differences in cell type proportion ( in "cell type proportion raw"), indicating that while the gene expression is different between disease outcome, the proportion of cell types are similar. Instead, pericytes, glia, microvascular, and inflammatory fibroblasts were found to be the top four cell types that exhibit differential proportion between healthy and non-inflamed biopsies (Supplementary Figure 6 ). These two feature types offer different perspectives from the same data and reveal distinct collections of cell types where one group is more concerned with changes in expression and the other collection is more concerned with changes in proportion. It would have been challenging or impossible to accurately disentangle the contributions of cell type percentage and cell specific gene expression in classical bulk gene expression data. These observations not only highlights the necessity of single-cell research, but it also emphasises the significance of evaluating various feature types, as generated by scFeatures. scFeatures uncovers data features associated with survival outcome from spatial proteomics To demonstrate the utility of scFeatures at extracting spatial information, we applied scFeatures to a spatial proteomics dataset of tumors from triple negative breast cancer patients. The question of interest is classifying tumors based on cellular organisation into distinct types that are associated with patient survival. The original study defined three tumor groups based on mixing scores, where a "cold group" is identified by low immune infilture, a "compartmentalised group" is identified by compartments formed by almost entirely of either tumour or immune cells, and a "mixed group" is when there is no clear boundary separating the tumor and immune cells. The nearest neighbour correlation is a feature type in scFeatures that was created primarily to capture spatial co-expression patterns. It computes the correlation of a cell's protein expression with that of its nearest neighbour. Therefore, spatial organisation of cells, such as whether tumor cells are next to immune cells would affect the correlation of protein expression of cells with neighbouring cells. To construct this feature type, we used scFeatures on selected "triple negative breast cancer" samples from the dataset and clustered the resulting features (Fig. 4b) . Survival analysis using the Kaplan-Meier Curve revealed differences between survival outcomes of individuals from the two clusters (P-value of 0.07, Fig. 4c ), compared to the patient group defined in the original study with P-value of 0.22. This suggests that the new patient subgroup found by scFeatures has greater association with the survival outcomes and demonstrates the ability of the spatial feature category at representing spatial organisations and uncovering novel patterns in the data. In summary, scFeatures creates a multi-view molecular representation of individuals by generating over tens of thousands of interpretable features based on single-cell and spot-based spatial data. The innovation and motivation scFeatures lies in the generation of various literature motivated and biologically relevant feature vectors for phenotype disease modelling and disease prediction. We have designed 17 feature types across six categories based on a broad range of analytical approaches in literature from cell type specific gene expression to measures of cellcell (ligand-receptor co-expression) interaction and demonstrated that the feature types are diverse with low correlation amongst them. We demonstrated scFeatures on scRNA-seq data from ulcerative colitis and discovered a number of features linked with disease characteristics and extracting spatial features from a triple negative breast cancer proteomics data resulted in the stratification of tumours that are more strongly related with survival outcomes than the original study's subgroups. The features vector generated by scFeatures can be used for a broader set of downstream applications and not limited to the ones illustrated in the case studies. For example, given the features vectors are generated at the sample level, this opens the opportunity for the exploration of differential patient response to diseases due to heterogeneity between individuals. Even for patients recorded as responders to a treatment, the extent of response and the change at omics level varies between individuals. The feature vector can be subjected to latent class analysis, which has typically been applied on single-cell level for exploring cellular diversity 15, 16 , to enable detection of sub-populations in the cohort, as well as the biology driving patient heterogeneity. The multiple feature representations generated by scFeatures can be considered as multiple views of the data and as such leads naturally to multi-view learning. This is one of the many collections of methods that perform integration across multiple features classes to enhance model performance. There exists a number of approaches for performing data integration 17 , from the simple concatenation of features from all feature types into a single vector as the input, to incorporating and optimising the data integration procedure within the model training process. While current multi-view learning in bioinformatics typically refers to the use of multiple omics obtained from the same sample 18 , we envisage the generation of multiple features types by scFeatures opens new opportunities for multi-view learning from single omic type. scFeatures is currently designed to perform feature engineering for single-cell RNA-seq, spatial proteomics and spatial transcriptomics data, but the framework is not limited to these platforms. Taking chromatin accessibility as an example, a commonly used analysis strategy is assigning genes based on nearby peaks, thereby converting the peak matrix to a matrix of gene activity scores similar to gene expressions 19 . Using this approach, all feature classes designed for scRNA-seq are then applicable to chromatin accessibility data. In future, we plan to extend scFeatures to other single-cell omics such as single-cell DNA methylation, single-cell chromatin accessibility and single-cell genomics, leveraging the common analytical approach in these areas and construct specific feature classes. For chromatin accessibility, the co-accessibility between pairs of peaks, which is used to predict cis-regulatory interactions, can be constructed and stored as a vector for each sample. The correlation values between transcription factors (TF) motifs can be readily constructed as another class of feature representation vector, and can be used to identify the modules of TF motifs affected in disease state. With the recent surge of cohort based single-cell studies and the number of tools for characterising individual cells, there is an increased demand for defining samples in a study based on their cellular characterization to guide better understanding of disease and health. Here, we presented scFeatures, a tool that provides a multi-view extraction of molecular features from single-cell and spot-based spatial data to characterize cellular features of each individual. scFeatures efficiently extracts collections of interpretable features from large-scale data and we demonstrated its ability to derive biological insights in scRNA-seq and spatial data. We envision that scFeatures, a public R package available at https://github.com/SydneyBioX/scFeatures, will facilitate better understanding of single-cell data from a sample (i.e. patient) perspective and the signatures underlying disease conditions from different angles. Data collection and processing scRNA-seq To demonstrate scFeatures on scRNA-seq data, we collected data from four published studies and curated a total of 15 datasets from the studies. The data are described in detail below: Six Ulcerative Colitis datasets: The UC data 13 sequenced healthy control, inflamed and noninflamed colon biopsies from multiple patients. The data was retrieved from Single Cell Portal with accession ID SCP259. We subset the data into epithelial, stromal cells and immune subset according to the original publication, resulting in the following 6 datasets: • UC inflamed vs non-inflamed (Imm) where Epi stands for epithelial, Fib stands for stromal and Imm stands for immune subsets. Inflamed, non-inflamed and healthy are patients' conditions of interest. Six Lung datasets: The lung data 20 sequenced healthy control, idiopathic pulmonary fibrosis (IPF), and chronic obstructive pulmonary disease (COPD) biopsies from multiple patients. The data was retrieved from Gene Expression Omnibus (GEO) with accession ID GSE136831. We subset the data into epithelial, stromal cells and immune subset according to the original publication, resulting in the following datasets: Two melanoma data 21 sequenced immune cells from tumor biopsies of melanoma patients prior to and after treatment with immune checkpoint therapy. The data was retrieved from GEO with accession ID GSE120575. We subset the data into pre-treatment and post-treatment datasets. The patients' conditions of interest in both datasets are non-responding and responding. The COVID dataset 22 sequenced peripheral blood mononuclear cells (PBMC) from COVID-19 patients. The data was retrieved from European Genome-phenome Archive (EGA) with accession ID EGAS00001004571. We subset the original data into mild and severe patients and consider the mild and severe disease stage as the patients' conditions of interest. The triple negative breast cancer dataset 23 measured the patient's protein expression using MIBI-TOF (multiplexed ion beam imaging by time of flight) technology. Data was obtained from https://mibi-share.ionpath.com. The amyotrophic lateral sclerosis dataset 24 sequenced lumbar spinal cord tissue of ALS and control mouse at varying time points using the spatial transcriptomics technology. The data was retrieved from GEO with accession ID GSE120374. We used the subset of data sequenced at the disease onset time point. We generated 17 feature types that can be broadly categorised into six categories: i) cell type proportions, ii) cell type specific gene expressions, iii) cell type specific pathway expressions, iv) cell type specific CCI scores, v) overall aggregated gene expressions and vi) spatial metrics. All feature types except for the overall aggregated gene expressions category have different implementations for scRNA-seq and spatial data to better leverage the characteristics of different data types and the implementation details are described in Supplementary Table 1. For spot-based spatial transcriptomics, we performed the following additional processing in order to allow certain feature classes to be applicable. First, since the cell type specific feature categories require cell type information while the spot in spot-based data contains a mixed population of multiple cells, we used Seurat's TransferData function to predict the cell type probability of each spot. A published scRNA-seq data on mouse spinal cord with cell type labels was used as the reference 25 . Then, given that each spot contains an unknown number of cells which vary across each spot, we weighted the contribution of each spot to the generated features by the relative number of cells it contains. We used library size as an estimate of the relative number of cells, motivated by a study that found a high correlation between the number of cells and library size of spots 26 . To calculate the relative number of cells, we binned the log2 transformed total library size of cells into 100 bins, and assigned each spot a relative number of cells ranging between 1 to 100 according to its bin. Given scFeatures constructs a standard matrix of samples by features, we can readily compute the Pearson's correlation between individual features. In detail, we first computed the correlation between individual features. The median correlation between pairs of feature classes was calculated by taking the absolute values of the individual correlation values of the features in the given pair of feature classes and then computing the median. For the correlation plot shown in Fig. 2b , we subsampled 100 features from feature classes that have more than 100 features to avoid the correlation plot being dominated by feature classes with more features. In scFeatures, we provide functionality to perform classification and survival analysis for the convenience of users. The classification function is a wrapper around a classification package classifyR 27 that was published by our group earlier. By default, we use a random forest model, set the number of folds to three, perform 20 cross-validation and calculate F1-score. These were also the settings used to report the classification performance in this study and can be specified by the user. The only exception being that 100 cross-validation was performed to obtain a more stable feature importance score for the case study on the "UC healthy vs noninflamed (Fib)" dataset. For survival analysis, we use a cox proportional-hazards model provided in the rms R package. By default, we set the number of folds to three, perform 20 cross-validation and calculate Cindex. Note that as the cox model is not designed to take in a large number of features at once, unlike a typical classification model, we input one feature from the generated feature class at a time for building the cox model. The best C-index is reported as the performance for the feature class. The runTests function in ClassifyR outputs the features selected by the classification model. Since repeated cross-validation was performed, this generated one set of included features for each cross-validation process. Based on all the derived sets, the frequency of inclusion was considered as the feature importance score of each feature. For the cell type specific feature category, given that each feature is associated with a cell type, it is also of interest to aggregate the feature importance score associated with each cell type. We approached by summing the feature importance score of all features associated with a cell type, then dividing by the number of features constructed for that particular cell type to adjust for the difference in the number of features per cell type. The final score was considered as the feature importance score of each cell type. To benchmark the scalability of the 17 features classes, we used the UC inflamed vs noninflamed (Imm) dataset and took random samples to construct datasets with 1000, 2000, 3000, 5000, 10000, 20000, 30000, 50000, 70000 and 100000 cells. Each dataset contains the same 15 patients and the same 15 cell types. For the purpose of evaluating the features classes designed for spot-based data which require each spot to be associated with a cell type probability vector, we treated each cell as a "spot" and randomly created a cell type probability vector for each cell. Similarly, for the purpose of evaluating the feature classes under the category spatial metrics which require spatial coordinates of each cell, we randomly assigned a pair of x and y-coordinates to each cell. In addition, the cell type probability and number of cells in each spot was randomly generated to represent such data. Runtime was measured using the built-in Sys.time function in R. Memory was measured by recording the peak resident set size, which measures the peak amount of memory that a process consumes across all cores. All code was run in parallel using 8 cores for three times and the average measurements were taken. All processes were carried out using a research server with dual Intel(R) Xeon(R) Gold 6148 Processor with 40 cores and 768 GB of memory. Figure 3 . Schematic representation of the calculation of correlation between feature types. a First, for a given dataset, the features from all feature types are created, yielding a samples by features matrix. Pearson's correlation is calculated on the features matrix to result in a typical correlation matrix comprising the correlation between the individual features, as shown in b. Since each feature is associated with a feature type, we can zoom into a section of the correlation matrix that contains the correlations of features from two feature types. For example, c shows the section of correlation matrix, which contains the features from the feature type "gene mean celltype" and "gene correlation aggregated". A boxplot can then be constructed to summarise the correlations between these two feature types. d shows another section of the correlation matrix, which contains the correlations between all the features from the feature type "gene correlation aggregated". e Repeating this across each section of the correlation matrix produces boxplots summarising the correlation between all pairwise combinations of feature types. For datasets with disease outcome, random forest was used and model performance was evaluated in terms of F1 score. For the dataset "Triple negative breast cancer" with survival outcome, cox proportional-hazard model was used and model performance was evaluated in terms of C-index. Each point represents the average from 50 cross-validation models. Wilcoxon test was performed on each cell type to compare the cell type proportion between the non-inflamed and healthy samples. Supplementary Table 1 . Proportion ratio scRNA-seq and spatial proteomics Computes the pairwise ratio of two cell types' proportions, i.e. cell type 1 divided by cell type 2. This is calculated for each paired cell type combination. To avoid dividing by zero when a cell type is not present in a patient, we add 1 to both the numerator and denominator. The range of value is then scaled using log2 transformation. Computes the pairwise ratio of two cell types' proportions based on the single cell representation as described in the implementation of "Proportion raw". scRNA-seq First, we run the ssgsea function from the GSVA package to obtain the gene set enrichment score for each single cell of a patient. The enrichment score is then summarised for each cell type by averaging the scores from all the single cells within a cell type. As a result, this approach converts the matrix of gene expressions by single cells into pathways by cell types for each patient. The matrix of pathways by cell types is further converted into a single vector by concatenating the scores from each cell type. spatial proteomics N/A as the number of proteins in spatial proteomics is generally too few to calculate pathway enrichment. We obtain the regression coefficients of each gene associated with each cell type as described in the implementation details of "Gene mean celltype". The regression coefficients for all the genes involved in a particular pathway are then summed. The summation is done separately for each cell type. 29 package to calculate the cellcell interaction probability between ligand and receptor pairs. This feature class is also cell type specific, as the interaction between ligand and receptor is quantified separately for each cell type. The final output is a vector of interaction probabilities for each sample. spatial proteomics N/A as the number of proteins is too small to query the cell-cell interactions. spatial transcriptomics N/A as calculation of cell-cell interaction relies on expression of individual cells. Overall aggregated gene expressions Gene mean aggregated scRNA-seq, spatial proteomics and spatial transcriptomics First the mean expression of genes across all cells is computed for each sample. We then restrict to the top variable genes using the same procedure as defined in "gene mean celltype". The number of variable genes is set to 1500 by default and can be specified by the user. Gene proportion aggregated scRNA-seq, spatial proteomics and spatial transcriptomics For each gene, we calculate the proportion that this gene is expressed across all cells for each patient. We then restrict to the top variable genes using the same procedure as defined in "gene mean celltype". The number of variable genes is set to 1500 by default and can be specified by the user. Gene correlation aggregated scRNA-seq, spatial proteomics and spatial transcriptomics We first obtain top variable genes using the same procedure as defined in "gene mean celltype". The number of variable genes is set to 100 by default and can be specified by the user. Then, for the selected genes, we calculate the pairwise correlation between two genes based on their expression values. The final output is a vector of gene-wise correlation. Spatial metrics L function scRNA-seq data N/A as there are no spatial coordinates. spatial proteomics The L values between the pairs of proteins are calculated using the L function defined in literature 30 and used as the features. L value greater than zero indicates spatial attraction of the pair of proteins whereas L value less than zero indicates spatial repulsion. We calculate the L function based on the single cell representation as described in the implementation of "Proportion raw". Cell type interaction scRNA-seq data N/A as there are no spatial coordinates. spatial proteomics We find the nearest neighbours of each cell and the cell types of these neighbours. These are considered as spatial interaction pairs. The cell type composition of the spatial interaction pairs is used as features. We assume that the nearest neighbours should be the cells captured within each spot and consider them as the spatial interaction pairs. We use single cell representation as described in the implementation of "Proportion raw" to calculate the following procedure: for a spot containing n 1 cell type x and n 2 cell type y, the spatial interaction composition of of cell type x with cell type x is calculated as n 1 / (n 1 +n 2 ) * n 1 / (n 1 +n 2 ). Similarly for the spatial interaction composition of cell type x with cell type y. We then sum the spatial interaction composition across all spots and use them as the features. Moran's I scRNA-seq data N/A as there are no spatial coordinates. spatial proteomics and spatial transcriptomics Moran's I are calculated using the function defined in literature 31 and used as the features. It calculates the spatial autocorrelation based on both the locations and values simultaneously. A value closer to 1 indicates clustering of similar values and a value closer to -1 indicates clustering of dissimilar values. A value of 0 indicates no particular clustering structure, ie, the values are spatially distributed randomly. Nearest neighbour correlation scRNA-seq data N/A as there are no spatial coordinates. Pearson correlation is calculated for the protein expression between a cell with its nearest neighbour cell for spatial proteomics and for gene expression between a spot with its nearest neighbour spot for spatial transcriptomics. Appendix: Integrating single-cell and spatial transcriptomics to elucidate intercellular tissue dynamics Feature selection revisited in the single-cell era Computational and analytical challenges in single-cell transcriptomics A comparison of automatic cell identification methods for single-cell RNA sequencing data Cepo uncovers cell identity through differential stability A comparison of single-cell trajectory inference methods The Role of Single-Cell Technology in the Study and Control of Infectious Diseases Tools for the analysis of high-dimensional single-cell RNA sequencing data Deciphering cell-cell interactions and communication from gene expression Gene Set Analysis: Challenges, Opportunities, and Future Research The Molecular Signatures Database (MSigDB) hallmark gene set collection Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles Intra-and Inter-cellular Rewiring of the Human Colon during Ulcerative Colitis A multi-step classifier addressing cohort heterogeneity improves performance of prognostic biomarkers in three cancer types Latent cellular analysis robustly reveals subtle diversity in large-scale single-cell RNA-seq data f-scLVM: scalable and versatile factor analysis for single-cell RNA-seq A review on machine learning principles for multi-view biological data integration Multiview learning for understanding functional multiomics Single-cell ATAC sequencing analysis: From data preprocessing to hypothesis generation Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment MIBI-TOF: A multiplexed imaging platform relates cellular phenotypes and tissue structure Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis Massively Parallel Single Nucleus Transcriptional Profiling Defines Spinal Cord Neurons and Their Activity during Behavior Transcriptional output, cell types densities and normalization in spatial transcriptomics ClassifyR: an R package for performance assessment of classification with applications to transcriptomics A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging Inference and analysis of cell-cell communication using CellChat The second-order analysis of stationary point processes Notes on continuous stochastic phenomena The authors declare no conflict of interest. All data used in this study are publicly available. The accession links are reported in the Methods section.Code availability scFeatures is publicly available as an R package at https://github.com/SydneyBioX/scFeatures.